This Summit Begins in...
Companies on the Program Include
Eliminating Risk & Ensuring Compliance in Biopharmaceutical R&D & Manufacturing Sites
As biopharmaceutical pipelines expand with increasingly complex modalities at a faster rate than ever, the landscape for EHS leaders is rapidly evolving.
Navigating the complexities of compliance regulations while safeguarding your workforce has never been more critical. With an increasing number of R&D and manufacturing facilities across large pharma, biotech, CDMOs, and CROs, handling potentially hazardous chemical and biological materials, the demand for robust biosafety, ergonomic, chemical, and environmental protocols is at an all-time high.
You’ll have the unique chance to network with a focused group of EHS leaders from Genentech, Eli Lilly, Takeda & more as they share high-level strategies and practical, day-to-day solutions. You’ll be in the company of over 60 global directors, strategic leaders, and heads of EHS from the world’s largest pharmaceutical and biotech organizations, all converging to shape the future of EHS&S in the industry.
With a mix of breakout sessions, hands-on workshops, and in-depth discussions, learning from real-world case studies that cater to both large multinationals and smaller companies. This is your opportunity to discover how to streamline EHS&S practices, from regulatory compliance to corporate strategy and site-level implementation.
This winter, San Diego is the place to be if you’re serious about enhancing your EHS&S strategy, eliminating risk, and ensuring compliance across your global operations. Join us to equip yourself with the knowledge, connections, and tools needed to protect your workforce and lead your organization to a safer, more sustainable future.
2024 FULL EVENT GUIDE
World-Class Speaker Faculty Includes:
Paul Ryan
Director - Environment Health & Safety ,Occupational Sustainability ,Research and development
Bristol Myers Squibb
Previous Attending Companies Include:
"My experience was truly enjoyable as there has never been an opportunity to get so many safety professionals together that are in Biopharma. It was great to share similar experiences and challenges that are unique to our field"
– Frieda Sanders, Associate Director, Environmental, Health & Safety, Kriya Therapeutics